This federal contract award, with ID SPE2DB20D1110|SPE2DB25FJ81S, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of a pharmaceutical product, GEMTESA 75 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,376.18 and an ultimate completion date of December 10, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award Management (SAM.gov) since 2002. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.
Generated 3/16/25, 12:46 AM